Untargeted Plasma Metabolomics and Gut Microbiome Profiling Provide Novel Insights into the Regulation of Platelet Reactivity in Healthy Individuals
暂无分享,去创建一个
H. Vlamakis | R. Xavier | M. Schirmer | L. Joosten | M. Netea | P. D. de Groot | C. Chiriac | Q. de Mast | A. J. van der Ven | M. H. Gasem | R. N. Tunjungputri | Nadira Vadaq | Edwin Ardiansyah | R. Tunjungputri | Cecilia M. Chiriac
[1] L. Zagrean,et al. Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review , 2021, Journal of clinical medicine.
[2] Guangji Wang,et al. Gut Microbial Metabolites of Aromatic Amino Acids as Signals in Host–Microbe Interplay , 2020, Trends in Endocrinology & Metabolism.
[3] C. Takacs-Vesbach,et al. Isotopic and genetic methods reveal the role of the gut microbiome in mammalian host essential amino acid metabolism , 2020, Proceedings of the Royal Society B.
[4] Oliver Fiehn,et al. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors , 2020, Cell.
[5] John C. Earls,et al. Blood metabolome predicts gut microbiome α-diversity in humans , 2019, Nature Biotechnology.
[6] P. Meikle,et al. Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability , 2019, Thrombosis and Haemostasis.
[7] Krista A. Zanetti,et al. Pre-Analytical Factors that Affect Metabolite Stability in Human Urine, Plasma, and Serum: A Review , 2019, Metabolites.
[8] H. Osborn,et al. Synthetic Flavonoids as Novel Modulators of Platelet Function and Thrombosis , 2019, International journal of molecular sciences.
[9] S. Narumiya,et al. Prostaglandin F2α Facilitates Platelet Activation by Acting on Prostaglandin E2 Receptor Subtype EP3 and Thromboxane A2 Receptor TP in Mice , 2019, Thrombosis and Haemostasis.
[10] M. Grenegård,et al. Individual variations in platelet reactivity towards ADP, epinephrine, collagen and nitric oxide, and the association to arterial function in young, healthy adults. , 2019, Thrombosis research.
[11] S. Smeekens,et al. The Inter-Relationship of Platelets with Interleukin-1β-Mediated Inflammation in Humans , 2018, Thrombosis and Haemostasis.
[12] Karsten Zengler,et al. GABA Modulating Bacteria of the Human Gut Microbiota , 2018, Nature Microbiology.
[13] R. Sturmey,et al. Glucose metabolism and metabolic flexibility in blood platelets , 2018, Journal of thrombosis and haemostasis : JTH.
[14] A. M. James,et al. Ischemic preconditioning protects against cardiac ischemia reperfusion injury without affecting succinate accumulation or oxidation. , 2018, Journal of molecular and cellular cardiology.
[15] David S. Wishart,et al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..
[16] Andrew D. Johnson,et al. ADP Platelet Hyperreactivity Predicts Cardiovascular Disease in the FHS (Framingham Heart Study) , 2018, Journal of the American Heart Association.
[17] M. Holinstat,et al. The expansive role of oxylipins on platelet biology , 2017, Journal of Molecular Medicine.
[18] M. During,et al. Inhibition of NMDA receptor function with an anti-GluN1-S2 antibody impairs human platelet function and thrombosis , 2017, Platelets.
[19] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[20] C. Huttenhower,et al. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity , 2016, Cell.
[21] Richard A. Notebaart,et al. Host and Environmental Factors Influencing Individual Human Cytokine Responses , 2016, Cell.
[22] S. Hazen,et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk , 2016, Cell.
[23] Zhang Yanyan,et al. Acetic acid in aged vinegar affects molecular targets for thrombus disease management. , 2015, Food & function.
[24] A. Franco,et al. Platelets at the interface of thrombosis, inflammation, and cancer. , 2015, Blood.
[25] Kyongbum Lee,et al. Prediction and quantification of bioactive microbiota metabolites in the mouse gut , 2014, Nature Communications.
[26] S. Bhattacharya,et al. The sex specific effects of extraneous testosterone on ADP induced platelet aggregation in platelet‐rich plasma from male and female subjects , 2014, International journal of laboratory hematology.
[27] C. Miller,et al. Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results , 2014, British journal of haematology.
[28] Y. Chiang,et al. Characteristics of endogenous γ-aminobutyric acid (GABA) in human platelets: functional studies of a novel collagen glycoprotein VI inhibitor , 2014, Journal of Molecular Medicine.
[29] F. Sinigaglia,et al. Dehydroepiandrosterone-sulfate inhibits thrombin-induced platelet aggregation , 2012, Steroids.
[30] Peter Donnelly,et al. Human metabolic profiles are stably controlled by genetic and environmental variation , 2011, Molecular systems biology.
[31] B. Olde,et al. Succinate independently stimulates full platelet activation via cAMP and phosphoinositide 3‐kinase‐β signaling , 2011, Journal of thrombosis and haemostasis : JTH.
[32] Andrew J. Johnson,et al. The role of prostanoid receptors in mediating the effects of PGE2 on human platelet function , 2010, Platelets.
[33] Andrew D. Johnson,et al. Genome-wide meta-analyses identifies 7 loci associated with platelet aggregation in response to agonists , 2010, Nature genetics.
[34] Chris I. Jones,et al. A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. , 2009, Blood.
[35] Adam M. Feist,et al. A genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that accounts for 1260 ORFs and thermodynamic information , 2007, Molecular systems biology.
[36] T. Keränen,et al. GABA and glutamate transporters are expressed in human platelets. , 2005, Brain research. Molecular brain research.
[37] M. Mcmurdo,et al. Comparison of Compositions and Metabolic Activities of Fecal Microbiotas in Young Adults and in Antibiotic-Treated and Non-Antibiotic-Treated Elderly Subjects , 2004, Applied and Environmental Microbiology.
[38] Liliana Jiménez,et al. Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.
[39] W. Erl,et al. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. , 2004, Blood.
[40] D. Vaughan,et al. Relationship Between Carbamoyl-Phosphate Synthetase Genotype and Systemic Vascular Function , 2004, Hypertension.
[41] T. Saldeen,et al. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. , 2003, The American journal of clinical nutrition.
[42] Makoto Murakami,et al. Phospholipase A2 enzymes. , 2002, Prostaglandins & other lipid mediators.
[43] J. Freedman,et al. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. , 2001, The Journal of nutrition.
[44] M. Mauri,et al. Plasma and Platelet Amino Acid Concentrations in Patients Affected by Major Depression and under Fluvoxamine Treatment , 1998, Neuropsychobiology.
[45] Y. Hannun,et al. 15-Hydroxyeicosatetraenoic acid-mediated potentiation of thrombin-induced platelet functions occurs via enhanced production of phosphoinositide-derived second messengers--sn-1,2-diacylglycerol and inositol-1,4,5-trisphosphate. , 1992, Blood.
[46] M. Mayer,et al. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[47] G. L. Le Breton,et al. Prostaglandin H2 directly lowers human platelet cAMP levels. , 1983, Thrombosis research.